Davis Jennifer L. 4
4 · PROCTER & GAMBLE Co · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Davis Jennifer L.
CEO - Health Care
Transactions
- Exercise/Conversion
Common Stock
2025-12-03$144.35/sh+60.43$8,723→ 61,828.509 total - Tax Payment
Common Stock
2025-12-03$144.35/sh−60.43$8,723→ 61,768.079 total - Award
Restricted Stock Units
2025-11-17+33.958→ 262.66 total→ Common Stock (33.958 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-03−60.43→ 965.57 total→ Common Stock (60.43 underlying)
Holdings
- 15,535.303(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F2]Shares withheld to cover taxes on previous Restricted Stock Unit grant.
- [F3]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F4]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
- [F5]Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.